Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results

被引：0
|
作者：
Miron A Bogdan
Hisamichi Aizawa
Yoshinosuke Fukuchi
Michiaki Mishima
Masaharu Nishimura
Masakazu Ichinose
机构：
[1] Clinica Medic Or,
[2] Kurume University,undefined
[3] Juntendo University,undefined
[4] Kyoto University,undefined
[5] Hokkaido University,undefined
[6] Wakayama Medical University,undefined
来源：
BMC Pulmonary Medicine | / 11卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Salmeterol; Formoterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The efficacy and safety of combination salmeterol (50 μg)/fluticasone propionate (500 μg) inhalation twice daily via accuhaler in Chinese patients with COPD
    Zheng, Jin-Ping
    Yang, Lan
    Wu, Ya Mei
    Chen, Ping
    Wen, Zhong Guang
    Huang, Wen-Jie
    Shi, Yi
    Wang, Chang-Zheng
    Huang, Shao-Guang
    Sun, Tie-ying
    Wang, Guang-Fa
    Xiong, Sheng-Dao
    Zhong, Nan-Shan
    CHEST, 2007, 132 (06) : 1756 - 1763
  • [22] Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study
    Zheng, Jinping
    Zhong, Nanshan
    Newlands, Amy
    Church, Alison
    Goh, Aik H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1753 - 1767
  • [23] An 12-week, Randomised, Parallel-group, Phase III Study comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 μg and Twice-daily Budesonide Swinghaler 200 μg During Step-down in Well Controlled Asthma
    Nakwan, Narongwit
    Perkleang, Thitima
    Tamsawai, Thanida
    Taptawee, Pattarawadee
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] Efficacy and safety of etanercept in patients with psoriasis: Results of a global phase III study
    Elewski, BE
    Boh, E
    Papp, K
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P159 - P159
  • [25] Efficacy and safety of Enbrel® (etanercept) in patients with psoriasis:: results of a phase III study
    Lowe, N
    Yamauchi, P
    Zitnik, R
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 20 - 20
  • [26] Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)
    Kerwin, Edward M.
    D'Urzo, Anthony D.
    Gelb, Arthur F.
    Lakkis, Hassan
    Garcia Gil, Esther
    Caracta, Cynthia F.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (02) : 90 - 101
  • [27] AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
    Sethi, Sanjay
    Kerwin, Edward
    Watz, Henrik
    Ferguson, Gary T.
    Mroz, Robert M.
    Segarra, Rosa
    Molins, Eduard
    Jarreta, Diana
    Garcia Gil, Esther
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 667 - 682
  • [28] Bronchodilator efficacy of tiotropium/formoterol (18/12 μg once daily via a Discair inhaler), tiotropium alone (18 μg by Handihaler) or combined with formoterol (12 μg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD
    Yildiz, Birsen Pinar
    Bayraktaroglu, Mesut
    Gunen, Hakan
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2187 - 2196
  • [29] Efficacy and safety of indacaterol 75 μg once daily in patients with moderate-to-severe COPD: pooled analysis of two phase III trials..
    Donohue, James F.
    Siler, Thomas
    Kerwin, Edward M.
    Williams, James
    Kianifard, Farid
    McBryan, Danny
    PHARMACOTHERAPY, 2012, 32 (10): : E242 - E243
  • [30] One-Year Extension Study of ACCORD COPD I: Safety and Efficacy of Two Doses of Twice-daily Aclidinium Bromide in Patients with COPD
    D'Urzo, Anthony
    Kerwin, Edward
    Rennard, Stephen
    He, Thomas
    Garcia Gil, Esther
    Caracta, Cynthia
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 10 (04) : 500 - 510
12345